Case report: Vaccine-induced immune thrombotic thrombocytopenia complicated by acute cerebral venous thrombosis and hemorrhage after AstraZeneca vaccines followed by Moderna COVID-19 vaccine booster and surgery

Case report: Vaccine-induced immune thrombotic thrombocytopenia complicated by acute cerebral venous thrombosis and hemorrhage after AstraZeneca vaccines followed by Moderna COVID-19 vaccine booster and surgery

Vaccine-induced thrombotic thrombocytopenia (VITT) is a well-known complication of adenoviral vector COVID-19 vaccines including ChAdOx1 nCoV-19 (AstraZeneca) and Ad26. COV2.S (Janssen, Johnson & Johnson). To date, only a few cases of mRNA COVID-19 vaccine such as mRNA-1273 (Moderna) or BNT1...

Full description

Bibliographic Details
Main Authors: Quan-Ting Chen, Yi Liu, Yeu-Chin Chen, Chung-Hsing Chou, Yu-Pang Lin, Yun-Qian Lin, Ming-Chen Tsai, Bo-Kang Chang, Tsung-Han Ho, Chun-Chi Lu, Yueh-Feng Sung
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Neurology
Subjects:
vaccine-induced thrombotic thrombocytopenia
cerebral hemorrhage
Moderna booster
autoimmune heparin-induced thrombocytopenia
cerebral venous thrombosis
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.989730/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2022.989730/full

Similar Items